Eliciting carbohydrate-specific immune response against sialosides: success and challenges

Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients.

(2011) Vladimir Mulens et al.   Human vaccines & immunotherapeutics

Biosynthesis and production of polysialic acids in bacteria

(2010) Miguel Ángel Ferrero et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Carbohydrate vaccines: developing sweet solutions to sticky situations?

(2010) Rena D. Astronomo et al.   NATURE REVIEWS DRUG DISCOVERY

Uniquely human evolution of sialic acid genetics and biology

(2010) A. Varki   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Probing a sialyltransferase’s recognition domain to prepare α(2,8)-linked oligosialosides and analogs

(2009) Ping Zhang et al.   CHEMICAL COMMUNICATIONS

Immunotherapy for cancer: synthetic carbohydrate-based vaccines

(2009) Therese Buskas et al.   CHEMICAL COMMUNICATIONS

Sialic acids as regulators of molecular and cellular interactions

(2009) Roland Schauer   CURRENT OPINION IN STRUCTURAL BIOLOGY

Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience

(2009) Jianglong Zhu et al.   Expert Review of Vaccines

Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease

(2008) V. Padler-Karavani et al.   GLYCOBIOLOGY

Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?

(2008) Robin Wachowiak et al.   PEDIATRIC SURGERY INTERNATIONAL

Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants—Hakomori's concepts revisited

(2007) Reiji Kannagi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS